# VENLAFAXINE BESYLATE
> **NDA215429** · New Drug Application · Sponsor: ALMATICA · Approved 2022-06-29
## Drug
- **FDA Application Number:** NDA215429
- **Application type:** New Drug Application
- **Brand name:** VENLAFAXINE BESYLATE
- **Generic name:** VENLAFAXINE
- **Active ingredients:** VENLAFAXINE BESYLATE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ALMATICA
- **Manufacturer:** Almatica Pharma LLC
- **First approval:** 2022-06-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215429)
---
*AI Analytics · CC0 1.0*